Hormone that controls iron levels may be target for atherosclerosis treatment
Wednesday, November 16, 2011 - 10:00
in Health & Medicine
Researchers at Emory University School of Medicine have identified hepcidin, a hormone that regulates iron levels in the body, as a potential target for treating atherosclerosis.